InvestorNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Reports Finger-Prick Breakthrough for Nucleosome Detection in Sepsis

VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced a technical milestone with the successful detection of nucleosomes in capillary blood from critically ill patients with sepsis using a lateral flow finger-prick prototype. The study, conducted as part of the SUMMIT program, demonstrated the feasibility of detecting nucleosomes in capillary samples. The findings also […]